Legend Biotech Appoints Ingrid Zhang as CEO

08:37 AM EDT, 09/15/2026 (MT Newswires) -- Legend Biotech (LEGN) said Tuesday its board has appointed Ingrid Zhang as chief executive officer, effective immediately. Zhang succeeds Alan Bash, who will return to his role as president for Carvykti after serving as interim CEO since July 2026, the company said. Zhang most recently served as chief commercial officer at Novartis (NVS) International, the company said. Legend Biotech shares were up 2.6% in premarket activity Tuesday.